The Galesburg Clinic Pharmacy Inc is categorized under in Galesburg, IL and active since 1975.
The Galesburg Clinic Pharmacy Inc was established in 1975, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 446110 by the NAICS.
If you are seeking more information, feel free to contact Gregg Rinker at the company’s single location by writing to 3315 North Seminary St, Galesburg, Illinois IL 61401 or by phoning (309) 344-1000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | The Galesburg Clinic Pharmacy Inc |
| Contact Person: | Gregg Rinker |
| Address: | 3315 North Seminary St, Galesburg, Illinois 61401 |
| Phone Number: | (309) 344-1000 |
| Website Address: | osfgalesburgclinic.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1975 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 5912 |
| NAICS Code: | 446110 |
| Share This Business: |
The Galesburg Clinic Pharmacy Inc was started in 1975 to provide professional under the SIC code 5912 and NAICS code 446110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Gregg Rinker for inquiries that concern The Galesburg Clinic Pharmacy Inc by calling the company number (309) 344-1000, as your correspondence is most welcome. Additionally, the physical location of the single location of The Galesburg Clinic Pharmacy Inc can be found at the coordinates 40.986389,-90.363451 as well as the street address 3315 North Seminary St in Galesburg, Illinois 61401.
For its online presence, you may visit The Galesburg Clinic Pharmacy Inc’s website at osfgalesburgclinic.org and engage with its social media outlets through on Twitter and on Facebook.